Cited 0 times in
Dual-Phase 18F-FP-CIT PET in Corticobasal Syndrome
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Min, JH | - |
dc.contributor.author | Park, DG | - |
dc.contributor.author | Yoon, JH | - |
dc.contributor.author | An, YS | - |
dc.date.accessioned | 2022-01-14T05:16:45Z | - |
dc.date.available | 2022-01-14T05:16:45Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 0363-9762 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/19970 | - |
dc.description.abstract | Corticobasal syndrome is the most common phenotype of corticobasal degeneration (CBD). F-FP-CIT PET and MRI are not helpful in distinguishing CBD from idiopathic Parkinson disease. Dual-phase F-FP-CIT PET is a recently developed imaging that shows regional cerebral perfusion in the early phase and dopamine transporter density in the late phase. We investigated the usefulness of dual-phase F-FP-CIT PET imaging in 3 patients with corticobasal syndrome. This image highlights that the early phases of F-FP-CIT PET may reflect regional cerebral perfusion with a pattern very similar to that of regional glucose metabolism in CBD. | - |
dc.subject.MESH | Brain | - |
dc.subject.MESH | Diagnosis, Differential | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Neurodegenerative Diseases | - |
dc.subject.MESH | Positron Emission Tomography Computed Tomography | - |
dc.subject.MESH | Radiopharmaceuticals | - |
dc.subject.MESH | Tropanes | - |
dc.title | Dual-Phase 18F-FP-CIT PET in Corticobasal Syndrome | - |
dc.type | Article | - |
dc.identifier.pmid | 30371594 | - |
dc.subject.keyword | corticobasal syndrome | - |
dc.subject.keyword | corticobasal degeneration | - |
dc.subject.keyword | 18F-FP-CIT | - |
dc.subject.keyword | PET | - |
dc.subject.keyword | early phase | - |
dc.contributor.affiliatedAuthor | Yoon, JH | - |
dc.contributor.affiliatedAuthor | An, YS | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1097/RLU.0000000000002355 | - |
dc.citation.title | Clinical nuclear medicine | - |
dc.citation.volume | 44 | - |
dc.citation.number | 1 | - |
dc.citation.date | 2019 | - |
dc.citation.startPage | e49 | - |
dc.citation.endPage | e50 | - |
dc.identifier.bibliographicCitation | Clinical nuclear medicine, 44(1). : e49-e50, 2019 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
dc.identifier.eissn | 1536-0229 | - |
dc.relation.journalid | J003639762 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.